May 13, 2020 / 9:18 PM / 20 days ago

BRIEF-Viela Bio Announces Positive Interim Results From Phase 1B Study Of VIB7734

May 13 (Reuters) - Viela Bio Inc:

* VIELA BIO ANNOUNCES POSITIVE INTERIM RESULTS FROM A PHASE 1B STUDY OF VIB7734 IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS

* VIELA BIO - DOSE-DEPENDENT IMPROVEMENTS IN CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX SCORES IN STUDY

* VIELA BIO INC - FINAL RESULTS FROM COHORT 3 ARE EXPECTED IN 3Q 2020

* VIELA BIO INC - TRIAL WAS NOT POWERED TO DETECT STATISTICALLY SIGNIFICANT CHANGES IN PDC DEPLETION AND CLASI SCORES BETWEEN PLACEBO AND TREATMENT ARMS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below